ABSTRACT
Mortality of obese patients with severe sepsis is higher than non-obese patients. Thus far, a pathophysiologic mechanism has not been identified that explains this higher mortality. The central nervous system is now becoming increasingly recognized as a target organ in sepsis and the systemic inflammatory response syndrome and may hold clues to the deleterious affects of obesity in patients with sepsis syndrome. In this study, obese and non-obese mice were given LPS IP and the brains were harvested 2 hours after injection. The brains were processed and mRNA isolated and hybridized to a microarray chip and processed. Analysis of gene expression demonstrated distinct expression difference between the lean and obese animals. Ontology data supports clear differences between the lean and obese groups in the coagulation system, neuroendocrine system, lipid transport and insulin receptors. Approximately eighty genes were identified to show 10-fold differential expression between the obese and lean mice.
INTRODUCTION
Mortality of obese patients with sepsis is higher than in non-obese patients, and reported to be 23% as compared to 6% in the non-obese (1, 2) . Although the mechanism of worse outcomes in obese patients with sepsis is unknown, it has been suggested that obesity is associated with an altered immune response to a septic or inflammatory insult (3) (4) (5) . Since obesity has been an exclusion criterion in many sepsis trials, little is known about how obesity affects outcome or if the obese respond differently to therapy. In particular, little is known about how obesity affects cerebral function in sepsis. Because of the complex interactions associated with obesity and sepsis, standard investigational strategies do not allow examination of numerous tissues and biologic pathways simultaneously, and may not uncover the mechanisms by which obesity alters the immune response to a septic or inflammatory insult.
The deleterious effects of sepsis on organs such as the brain, liver, kidney and heart are well-recognized. The central nervous system is now becoming increasingly recognized as a target organ in sepsis and the systemic inflammatory response syndrome. Cerebral dysfunction manifests with a spectrum ranging from mildly altered sensorium to coma. Historically, the encephalopathy of sepsis was attributed to functional effects of false neurotransmitters (6, 7) or alterations in cerebral blood flow (8) . More recent investigations in animal models have revealed morphological changes, including perimicrovascular edema and neuronal apoptosis, suggesting loss of bloodbrain barrier function and/or the involvement of cytokinemediated injury (9) .
A technique of examining numerous biologic pathways and tissues simultaneously is to identify cellular RNA expression through microarray technology. This technology allows large-scale identification of the RNA expressed within a tissue, and may allow identification of pathways not previously associated with obesity, inflammation or the cellular response to an infectious or inflammatory insult.
In this study we compared RNA expression in brain tissue between obese and non-obese mice after LPS injection in an attempt to identify expression patterns that may provide clues to the cerebral dysfunction in sepsis, and those that may differentially expressed in obese subjects following the inflammatory insult.
METHODS

Animal Model
Obese transgenic mice (-actin promoter driving agouti) and non-transgenic lean littermates were used as the model for the presence and absence of obesity, respectively (10) (11) (12) (13) . This mouse strain appears to provide a model of obesity having less immunologic interference than leptin deficient mice (14) . All mice were 6 weeks of age. The obese group mean weight was 51 grams and the lean was 29 grams.
Experimental Design
The study was designed as a two-way comparison between obese and non-obese mice (n=12), with half of each group receiving saline and the other receiving lipopolysaccharide (LPS).
Group 1 consisted of obese transgenic mice subjected to LPS challenge. Mice received 12 mg/kg of E. coli LPS (Sigma-Aldrich, St Louis, Mo) by intraperitoneal injection. Group 2 consisted of obese transgenic mice subjected to saline challenge. Mice in this group were treated identically to group 1 above except they received an equal volume sterile saline rather than LPS intraperitoneally. Group 3 consisted of non-transgenic littermates (non-obese) mice subjected to LPS challenge. Mice in this group were treated identically to group 1 above. Group 4 consisted of non-transgenic littermates (non-obese) mice subjected to saline challenge. Mice in this group were treated identically to group 2 above.
Animal procedures
All mice received either 12 mg/kg of E. coli LPS or equal volume of saline by intraperitoneal injection. The mice were observed and sacrificed two hours after receiving the injection. After the mice were euthanized, the brain was recovered by dissection of the skull and removal of the cortex. A coronal section was cut out of the mid cortex, 0.5 cm thick and included both hemispheres. This tissue was subsequently placed in a RNA preservative (RNALater, Quiagen, Valencia, CA, http://www.qiagen.com) and frozen to -70°C. for later RNA extraction and analysis. Animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee.
RNA isolation and microarray hybridization
The tissue was removed from the RNA preservative and homogenized in a buffered solution. The isolation was performed utilizing the RNeasy® Mini Kit (Qiagen). A highly denaturing cell-lysis buffer containing guanidine isothiocyanate (GITC) immediately generates an RNase-free environment, stabilizes the RNA, and simultaneously releases the DNA. The cellular extract is prepared, the conditions adjusted to allow separation of RNA and DNA, and the extract loaded onto the QIAGEN-tip. Total RNA and a portion of the genomic DNA present in the sample bind to QIAGEN Resin while the remaining DNA passes through in the first flow-through fraction. Residual proteins, metabolites and low-molecular-weight impurities are removed by washing the QIAGEN-tip with a medium-salt buffer. Pure RNA is eluted in a high-salt buffer while DNA remains bound to the resin. The RNA is then concentrated and desalted by isopropanol precipitation.
For simultaneous isolation of genomic DNA and RNA from the same sample, the first flow-through is reapplied to the QIAGEN-tip after elution of the RNA in order to bind the rest of the genomic DNA. The column is washed again, and the genomic DNA is eluted. Concentration and desalting of the RNA and DNA by isopropanol precipitation can then be performed in parallel. RNA samples were test for quantity and quality utilizing photospectrometry.
An initial test hybridization was performed, once these samples satisfied this quality control measure, they were hybridized to the MU 74 Av2® oligonucleotide chip (Affymetrix, Santa Clara, CA, http://www.affymetrix.com), hybridized and labeled. The chips were scanned with an Agilent Technologies (Palo Alto, CA, http://www.agilent.com) GeneArray® scanner.
Data analysis
Initial data review and preparation was conducted with Microarray Suite 5.0 (Affymetrix, Santa Clara, CA, http://www.affymetrix.com). The acquired image files were visually inspected for aberrations. The mean intensity of the four quadrants of each image file was determined to ascertain that data acquisition on each chip was uniform (< 5% deviation). Grid alignment was manually verified on each sample before calculation of probe intensities. Cell expression values were obtained using the standard Affymetrix calculations, which include (1) background subtraction with a smoothing adjustment, (2) noise correction to avoid negative values, (3) subtraction of ideal mismatch values, (4) application of Tukey's biweight algorithm on log-transformed values to obtain a robust mean estimate, and (5) scaling using the mean trimmed of the upper and lower 2% of observations (15) . The resulting expression datasets were filtered to remove the Affymetrix control probe sets, and all probe sets in which the detection calls were absent across all four groups, leaving 7341 expression levels for further analysis.
Clustering analysis was performed with Hierarchical Clustering Explorer 2.0 (University of Maryland) (16) . Prior to clustering, the dataset was log transformed then normalized with the z-transform across the overall mean expression value. The distance metric used was the Pearson correlation distance, and the clustering was performed with the UPGMA algorithm. Differential expression analysis was performed on the dataset prepared by normalizing the mean values to that of the baseline (lean saline, LS) group.
RESULTS
The heat map derived from hierarchical clustering of the filtered, normalized dataset, along with greatest differential expression sub-clusters and their general annotation, is given in Figure 1 . After evaluating the Table 1. data of the most highly expressed genes, several systems that are known to be relevant in sepsis and inflammation deserve special mention.
Coagulation System
The microarray data in this study show that the protein C receptor expression is less in the obese LPS group compared to the lean LPS group although it did not reach 10 fold differences. The opposite is true for plasminogen activator inhibitor 1 (PAI-1) which shows an 8.5 fold higher expression level in the obese LPS group compared to the lean LPS group. Plasminogen expression is also higher in the obese LPS group demonstrating a 5 fold increase. No difference was noted in either expression of these genes in the saline groups. Coagulation factor II gene (Locus Link 14061) also demonstrated increased expression in the obese LPS group compared to the lean along with coagulation factor V (Locus Link 14067). These fold changes are shown in Figure 3. 
Neuro-endocrine System
Analysis of RNA expressed in neuro-endorine function ( Figure 4 ) demonstrates increased expression of insulin-like growth hormones, serine protease inhibitors and vasopressin. Further, there is a 16-fold increase oxytocin-neurophysin expression in obese mice administered LPS compared to what lean mice injected with LPS. Of note is the down regulation of the insulin receptor after LPS stimulation in lean mice challenged with LPS. These expression patterns are specific for the obese LPS mice and not seen in the lean mice given LPS or the obese mice subjected to saline administration.
Lipid Transport
A significant increase in RNA expression is each of the majority of the apolipoproteins (A-I, A-II, A-IV, A-V, C-II, C-IV, F and H) was demonstrated in only the obese LPS-treated mice as compared with the lean LPS-treated mice ( Figure 5 ). The remaining apolipoproteins had no change in expression level between these two groups.
Insulin
Comparing the lean and obese mice that received LPS, one finding stands out. The insulin receptor in the obese group is significantly down-regulated compared to the lean group. This difference is shown in Figure 6 . With our recent understanding of insulin's intricate involvement in the inflammatory process, this decreased expression may offer some insight into the chronic inflammatory state of obesity and the response of the obese to an inflammatory insult (17).
DISCUSSION
The use of microarray in profiling biologic functions or as a discovery tool has proven itself as a valuable tool in many disciplines including neuroscience. The ability to investigate numerous biologic functions and pathways has added an additional tool in neuroscience research. Studying complex issues like sepsis, in a complex model such as obesity, would be daunting if not impossible, without this technology. However, there is a paradigm shift away from isolated molecular investigation to multi-system approach. This has placed more burdens on the bioinformatist or biostatistician and has positioned computational methods and technologies central in the research plan and design.
The recent use of microarray technology has allowed the examination of large-scale gene expressions in a variety of diseases including inflammatory states (18) (19) (20) (21) . Examining large-scale gene expression provides an opportunity to develop an expression pattern or profile that is unique to a stimulus or the host. This unique profile can provide define the biologic pathways that contribute to or are activated by the host's response to an insult or injury.
Current microarray chips allow whole genome evaluation in both the human and mouse. Using this whole genome approach, a large-scale analysis of the RNA signature of multiple organs is possible. Specific gene chips that identify major cytokines require pre-determination of areas to investigate and prevent observation of the genomic influences of unrecognized pathways that may be operational. Narrowing the genes investigated also reduces the chance of identifying pathways or genes that may be involved in obesity and immune response that have not previous been identified.
This study demonstrates the power of microarray technology by identifying several pathways that may help better understand the neuro-endocrine response to an inflammatory insult and identities pathways that may help in the understanding of the influence obesity has on the brains response to sepsis or inflammation. The most obvious standout is the changes noted in the coagulation systems. Two genes deserve special mention due to their relation to sepsis. In the past several years the interplay between sepsis, organ failure and the coagulation system has been extensively investigated (22) . Patients with severe sepsis demonstrate decreased concentration of protein C and elevated PAI-1 resulting in decreased fibrinolysis and increased thrombogenesis (23) . This tendency promotes microvascular clotting, tissue hypoxia and subsequent organ dysfunction. As shown in Figure 3 , the expression pattern would appear to promote intravascular coagulation and poor fibrinolysis. This requires validation and further investigation noting the heightened interest in the sepsis/coagulation axis.
The neuro-endocrine and lipid transport systems also require further investigation and validation. Noting the changes in GABA receptor expression may expand our understanding of the brain response to severe infection and inflammation and may lead to further insights in understanding sepsis associated encephalopathies.
The differential expression of the obese and lean in the insulin gene and receptor is intriguing. Obesity is known to be a "low grade" inflammatory process with well documented increases in TNF and known exaggerated cytokines responses to inflammatory stimulus (3, 5) . Insulin is known to inhibit NF kappa B activity which is the nuclear trigger of numerous inflammatory cytokines. The reduced expression of the insulin gene and, more importantly the insulin receptor may provide some insight into this inflammatory state documented in the obese.
CONCLUSIONS
This study has demonstrated that substantial differences the genomic expression profiles of obese and lean mice after LPS injection exist. Seventy eight genes were statistically isolated to show a greater than 10-fold expression difference between the obese and lean mice following induction of inflammation. These expression profiles suggest unfavorable coagulation expressions in the obese, along with alterations in GABA receptors, lipid transport and down regulation in insulin and insulin receptor.
